AAAAAA

   
Results: 1-9 |
Results: 9
ACUTE MYELOID-LEUKEMIA IN THE ELDERLY - A CRITICAL-REVIEW OF THERAPEUTIC APPROACHES AND APPRAISAL OF RESULTS OF THERAPY
Authors: FERRARA F MIRTO S ZAGONEL V PINTO A
Citation: F. Ferrara et al., ACUTE MYELOID-LEUKEMIA IN THE ELDERLY - A CRITICAL-REVIEW OF THERAPEUTIC APPROACHES AND APPRAISAL OF RESULTS OF THERAPY, Leukemia & lymphoma, 29(3-4), 1998, pp. 375-382
THERAPEUTIC OPTIONS AND TREATMENT RESULTS FOR PATIENTS OVER 75 YEARS OF AGE WITH ACUTE MYELOID-LEUKEMIA
Authors: FERRARA F ANNUNZIATA M COPIA C MAGRIN S MELE G MIRTO S
Citation: F. Ferrara et al., THERAPEUTIC OPTIONS AND TREATMENT RESULTS FOR PATIENTS OVER 75 YEARS OF AGE WITH ACUTE MYELOID-LEUKEMIA, Haematologica, 83(2), 1998, pp. 126-131
FLUDARABINE, CYTARABINE, AND G-CSF (FLAG) FOR THE TREATMENT OF POOR-RISK ACUTE MYELOID-LEUKEMIA
Authors: MONTILLO M MIRTO S PETTI MC LATAGLIATA R MAGRIN S PINTO A ZAGONEL V MELE G TEDESCHI A FERRARA F
Citation: M. Montillo et al., FLUDARABINE, CYTARABINE, AND G-CSF (FLAG) FOR THE TREATMENT OF POOR-RISK ACUTE MYELOID-LEUKEMIA, American journal of hematology, 58(2), 1998, pp. 105-109
INTERLEUKIN-2 THERAPY IN RELAPSED ACUTE MYELOGENOUS LEUKEMIA
Authors: MELONI G VIGNETTI M POGLIANI E INVERNIZZI R ALLIONE B MIRTO S SICA S LEONI F SELLERI C MANDELLI F
Citation: G. Meloni et al., INTERLEUKIN-2 THERAPY IN RELAPSED ACUTE MYELOGENOUS LEUKEMIA, The cancer journal from Scientific American, 3, 1997, pp. 43-47
FLUDARABINE, CYTARABINE AND G-CSF (FLAG) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (MDS)
Authors: FERRARA F MIRTO S MONTILLO M MELE G TEDESCHI A CIOLLI S ANNUNZIATA M COPIA C MAGRIN S LEONI F
Citation: F. Ferrara et al., FLUDARABINE, CYTARABINE AND G-CSF (FLAG) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (MDS), Blood, 90(10), 1997, pp. 371-371
OUTCOME OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA WHO FAILED TO RESPONDTO A SINGLE COURSE OF FIRST-LINE INDUCTION THERAPY - A GIMEMA STUDY OF 218 UNSELECTED CONSECUTIVE PATIENTS
Authors: LISO V IACOPINO P AVVISATI G PETTI MC BROCCIA G CAROTENUTO M FALDA M FAZI P LAZZARINO M LEONI P MIRTO S PUCCI G NOBILE F NOSARI AM SPECCHIA G STASI R TABILIO A MANDELLI F
Citation: V. Liso et al., OUTCOME OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA WHO FAILED TO RESPONDTO A SINGLE COURSE OF FIRST-LINE INDUCTION THERAPY - A GIMEMA STUDY OF 218 UNSELECTED CONSECUTIVE PATIENTS, Leukemia, 10(9), 1996, pp. 1443-1452
SERUM LDH VALUE AS A PREDICTOR OF CLINICAL OUTCOME IN ACUTE MYELOGENOUS LEUKEMIA OF THE ELDERLY
Authors: FERRARA F MIRTO S
Citation: F. Ferrara et S. Mirto, SERUM LDH VALUE AS A PREDICTOR OF CLINICAL OUTCOME IN ACUTE MYELOGENOUS LEUKEMIA OF THE ELDERLY, British Journal of Haematology, 92(3), 1996, pp. 627-631
TRANSPLANTATION OF ALLOGENEIC PBSC IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Authors: MAJOLINO I SCIME R BUSCEMI F INDOVINA A VASTA S SANTORO A PAMPINELLA M CATANIA P CAVALLARO AM FIANDACA T FABBIANO F MIRTO S MARCENO R CARONIA F
Citation: I. Majolino et al., TRANSPLANTATION OF ALLOGENEIC PBSC IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Experimental hematology, 23(8), 1995, pp. 755-755
TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE - REPORT OF 2 FURTHER CASES WITH AN IMMUNOHISTOCHEMICAL ANALYSIS
Authors: ARICO M NOTO G PRAVATA G BONGIORNO MR MIRTO S MALIZIA G
Citation: M. Arico et al., TRANSFUSION-ASSOCIATED GRAFT-VERSUS-HOST DISEASE - REPORT OF 2 FURTHER CASES WITH AN IMMUNOHISTOCHEMICAL ANALYSIS, Clinical and experimental dermatology, 19(1), 1994, pp. 36-42
Risultati: 1-9 |